Skip to main content
$369.62 $2.12 (0.6%)

10:54 AM EST on 01/22/21

DexCom, Inc. (NASDAQ:DXCM)

CAPS Rating: 5 out of 5

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.

Current Price $369.62 Mkt Cap $35.3B
Open $367.63 P/E Ratio 148.33
Prev. Close $367.50 Div. (Yield) $0.00 (0.0%)
Daily Range $365.28 - $373.99 Volume 117,259
52-Wk Range $182.07 - $456.23 Avg. Daily Vol. 1,050,510

Caps

How do you think NASDAQ:DXCM will perform against the market?

Add Stock to CAPS Watchlist

All Players

311 Outperform
94 Underperform
 

All-Star Players

145 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DXCM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFacarchidi (59.97)
Submitted November 05, 2020

Great product-market fit, good revenue growth, and a strong strategic plan to capture additional pieces of the diabetes care chain.

TMFjimhalley (63.43)
Submitted November 13, 2020

The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.

Recent Community Commentary

Read the most recent pitches from players about DXCM.

Recs

0
Member Avatar jhendricks316 (< 20) Submitted: 1/18/2021 1:42:13 PM : Outperform Start Price: $352.23 NASDAQ:DXCM Score: +3.19

My partner is a T1D and has never said anything negative about their technology.

Recs

0
Member Avatar XMFmoatster (99.54) Submitted: 11/15/2020 12:02:49 PM : Outperform Start Price: $336.40 NASDAQ:DXCM Score: +3.24

Was recently added to Nasdaq 100, I support it.
~65% gross margin in recent quarters
~18 P/S recently

Quarterly YoY growth numbers:
09-2020 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
26% 34% 44% 37% 49% 39% 52% 53% 44% 42% 30%

Recs

1
Member Avatar TMFjimhalley (63.43) Submitted: 11/13/2020 2:40:16 PM : Underperform Start Price: $335.35 NASDAQ:DXCM Score: -2.52

The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.

Leaderboard

Find the members with the highest scoring picks in DXCM.

Score Leader

ardys13

ardys13 (< 20) Score: +9,482.04

The Score Leader is the player with the highest score across all their picks in DXCM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ardys13 < 20 2/9/2009 Outperform 1Y $3.70 +9,827.84% +345.80% +9,482.04 1 Comment
bigrick22 90.59 3/24/2008 Outperform NS $4.00 +9,083.25% +197.53% +8,885.72 0 Comment
CleverKat 72.58 3/24/2008 Outperform NS $4.27 +8,502.58% +194.29% +8,308.29 0 Comment
cpalerm 94.85 3/23/2009 3/13/2014 Outperform 5Y $4.32 +8,403.01% +390.82% +8,012.18 1 Comment
MEGIN7790 < 20 4/4/2008 Outperform NS $4.45 +8,154.61% +188.64% +7,965.97 0 Comment
LazyTimeMoney 67.68 4/7/2008 Outperform NS $5.04 +7,188.29% +188.15% +7,000.14 0 Comment
jabrink 76.84 4/7/2008 Outperform 3W $5.07 +7,145.17% +187.92% +6,957.25 0 Comment
GriffinRex 89.13 4/8/2008 Outperform 3M $5.17 +7,005.03% +191.15% +6,813.88 0 Comment
cash4metoo 58.94 5/28/2009 Outperform 1Y $5.34 +6,778.84% +327.23% +6,451.61 0 Comment
YahooSIRIous 70.05 7/13/2009 Outperform 5Y $5.35 +6,765.98% +335.19% +6,430.79 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DXCM.